Forteo - Drug Details
๐Ÿ“Š Estimates Forteo Dialyzability By Different_Modalities

Forteo

Complete Drug Information

Drug Name
Forteo
Trade Names
Forteo, Forsteo
Pregnancy Category
AU: B3
Bioavailability
95%
Routes of Administration
Subcutaneous
Metabolism
Liver (nonspecific proteolysis)
Elimination
Subcutaneous: 1 hour
Excretion
Kidney (metabolites)
Formula
C181H291N55O51S2
Molar Mass
4117.77
Volume of Distribution
C181H291N55O51S2

๐Ÿคฐ Pregnancy Category Information

Category: AU: B3

Drugs which have been taken by only a limited number of pregnant women and women of childbearing age, without an increase in the frequency of malformation or other direct or indirect harmful effects on the human fetus. Animal studies have shown evidence of an increased occurrence of fetal damage, the significance of which is considered uncertain in humans.